课题基金 / 基金详情

项目摘要

项目成果

Sean Hartig的其他基金

相似基金

相关文献

中文摘要
翻译

英文摘要
 DESCRIPTION (provided by applicant): Insulin resistance and type 2 diabetes are predicted to affect 33% of the US population by 2050. Type 2 diabetes reflects the inability to store surplus energy derived from calories in fat cells. Obese fat displays a pro-inflammatory phenotype, which is partly responsible for the metabolic dysfunction and insulin resistance that precedes type 2 diabetes. Recent work challenges the idea that the all immune response is deleterious to adipose tissue. In particular, regulatory T cells (Tregs) counteract the proinflammatory response in adipose tissue to potentiate insulin sensitivity. We have discovered that overexpression of the microRNA miR-30a in subcutaneous adipose tissue of diabetic mice promotes insulin sensitivity. Through the use of RNA-seq and flow cytometry, we observed that the metabolic effects of miR-30a overexpression in subcutaneous adipose tissue are associated with increased recruitment of Tregs, which suppress local inflammation. In addition, we found that expression of miR-30a and the master controller of Treg function, Foxp3, are reduced in subcutaneous adipose tissue from insulin resistant compared to insulin sensitive human subjects. We hypothesize miR-30a promotes insulin sensitivity by stimulating the function of Tregs in subcutaneous adipose tissue. Two specific aims are proposed to critically test our hypothesis: (1) determine the role of Tregs in mediating anti-diabetic effects of miR-30a; (2) determine how miR-30a affects Treg polarization. The rationale for the proposed research plan is that identifying the mechanism underlying the beneficial effects of miR-30a expression in subcutaneous adipose tissue will lead to therapeutic strategies to enhance metabolic flexibility in subcutaneous adipocytes and thereby prevent type 2 diabetes. If our hypothesis is true, miR-30a might be exploited in novel therapies to manage insulin resistance and type 2 diabetes. We anticipate that our studies will provide new clues into the complex regulatory networks controlling energy balance in subcutaneous adipose tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITY
  • 批准号:
    10775353
  • 项目类别:
  • 资助金额:
    $19.77万
  • 财政年份:
    2023
  • 负责人:
    Sean Hartig
  • 依托单位:
An anti-diabetic microRNA that promotes metabolically healthy obesity
  • 批准号:
    9367450
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2017
  • 负责人:
    Sean Hartig
  • 依托单位:
Metabolic Impacts of Type II Interferon Signals in Obesity
  • 批准号:
    10665744
  • 项目类别:
  • 资助金额:
    $53.78万
  • 财政年份:
    2017
  • 负责人:
    Sean Hartig
  • 依托单位:
An anti-diabetic microRNA that promotes metabolically healthy obesity
  • 批准号:
    10163161
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2017
  • 负责人:
    Sean Hartig
  • 依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制